CAMBRIDGE, Mass.--(BUSINESS WIRE)--Today, MPM Capital (“MPM”), one of the world’s leading biotech investment firms, announced that it has raised $850 million for its second Oncology Impact Fund (“OIF ...
MPM operate premium wet cat food brands, including Applaws, Reveal and Encore 3i invested in MPM in 2020 MPM is based in Manchester UPDATED. Partners Group has agreed to acquire MPM Products, a global ...
Boston, MA, based Investment company Mpm Asset Management Llc (Current Portfolio) buys Oncorus Inc, sells Rhythm Pharmaceuticals Inc, Harpoon Therapeutics Inc during the 3-months ended 2021Q1, ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--MPM Capital (MPM), a biotechnology investment firm investing in early-stage therapeutics companies, today announced that Pankaj Bhargava, MD has joined its team of ...
New production capacity strengthens MPM Medical's position as a leading U.S. manufacturer and follows the company's recent launch of collagen at-home wound care kits MESQUITE, Texas, Dec. 16, 2025 ...
“We are delighted to announce the addition of Detlev to our investment committee,” said Ansbert Gadicke, M.D., MPM Managing Director. “Detlev’s leadership experience combined with the depth of his ...
Jan 5 (Reuters) - Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology company backed by major sector investor MPM BioImpact revealed ...
The MarketWatch News Department was not involved in the creation of this content. New production capacity strengthens MPM Medical's position as a leading U.S. manufacturer and follows the company's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results